Search

Author/Creator Egger, Thomas

1. Non-occupational and occupational factors associated with specific SARS-CoV-2 antibodies among hospital workers – A multicentre cross-sectional study. (September 2021)

Authors:
Kahlert, Christian R.; Persi, Raphael; Güsewell, Sabine; Egger, Thomas; Leal-Neto, Onicio B.; Sumer, Johannes; Flury, Domenica; Brucher, Angela; Lemmenmeier, Eva; Möller, J. Carsten; Rieder, Philip; Stocker, Reto; Vuichard-Gysin, Danielle; Wiggli, Benedikt; Albrich, Werner C.; Babouee Flury, Baha...
Journal:
Clinical microbiology and infection
Issue:
Volume 27:Number 9(2021)
Page Start:
1336
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Peripheral flow-MRD status at the time of autologous stem cell collection predicts outcome in multiple myeloma. (December 2018)

Authors:
Moor, Ivana; Bacher, Vera; Jeker, Barbara; Taleghani, Behrouz; Mueller, Beatrice; Keller, Peter; Betticher, Daniel; Egger, Thomas; Novak, Urban; Pabst, Thomas
Journal:
Bone marrow transplantation
Issue:
Volume 53:Number 12(2018)
Page Start:
1599
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Prolonged survival after second autologous transplantation and lenalidomide maintenance for salvage treatment of myeloma patients at first relapse after prior autograft. Issue 2 (24th January 2018)

Authors:
Gössi, Ursina; Jeker, Barbara; Mansouri Taleghani, Behrouz; Bacher, Ulrike; Novak, Urban; Betticher, Daniel; Egger, Thomas; Zander, Thilo; Pabst, Thomas
Journal:
Hematological oncology
Issue:
Volume 36:Issue 2(2018)
Page Start:
436
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Prolonged survival with increasing duration of lenalidomide maintenance after autologous transplant for multiple myeloma. Issue 2 (28th January 2019)

Authors:
Amsler, Isabel G.; Jeker, Barbara; Mansouri Taleghani, Behrouz; Bacher, Ulrike; Betticher, Daniel; Egger, Thomas; Zander, Thilo; Luethi, Jean-Marc; Novak, Urban; Pabst, Thomas
Journal:
Leukemia & lymphoma
Issue:
Volume 60:Issue 2(2019)
Page Start:
511
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Stem cell mobilization chemotherapy with gemcitabine is effective and safe in myeloma patients with bortezomib-induced neurotoxicity. Issue 5 (3rd May 2016)

Authors:
Mueller, Beatrice U.; Keller, Sandra; Seipel, Katja; Mansouri Taleghani, Behrouz; Rauch, Daniel; Betticher, Daniel; Egger, Thomas; Pabst, Thomas
Journal:
Leukemia & lymphoma
Issue:
Volume 57:Issue 5(2016:May)
Page Start:
1122
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Symptoms Compatible With Long Coronavirus Disease (COVID) in Healthcare Workers With and Without Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection—Results of a Prospective Multicenter Cohort. (28th January 2022)

Authors:
Strahm, Carol; Seneghini, Marco; Güsewell, Sabine; Egger, Thomas; Leal-Neto, Onicio; Brucher, Angela; Lemmenmeier, Eva; Meier Kleeb, Dorette; Möller, J Carsten; Rieder, Philip; Ruetti, Markus; Rutz, Remus; Schmid, Hans Ruedi; Stocker, Reto; Vuichard-Gysin, Danielle; Wiggli, Benedikt; Besold, Ulri...
Journal:
Clinical infectious diseases
Issue:
Volume 75:Number 1(2022)
Page Start:
e1011
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗